Bionor Pharma – Shares will trade exclusive of the right to receive subscription rights in the rights issue from today
(Oslo, Norway, 12 September 2016) Reference is made to the stock exchange announcement regarding subscription rights in the rights issue (the “Rights Issue”) of 525,000,000 new shares at a subscription price of NOK 0.10 per share in Bionor Pharma ASA (“Bionor” or the “Company”) dated 9 September 2016.
BIONOR PHARMA ASA
STOCK EXCHANGE ANNOUNCEMENT NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES
The shares in the Company will be traded exclusive of the right to receive subscription rights in the Rights Issue from and including today, 12 September 2016.
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
Unni Hjelmaas, Acting CEO, +47 915 19 651, email@example.com
Jens Krøis, CFO +45 2080 1668, firstname.lastname@example.org
Link to announcement in pdf